Cyclacel Pharmaceuticals, Inc. (CYCC) NASDAQ
6.37
-0.405(-5.98%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.27M |
| Enterprise Value | 7.77M |
| P/E Ratio | -1.91 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.56 |
| Price/Book Ratio | 0.88 |
| Enterprise/Revenue | -0.63 |
| Enterprise/EBITDA | 0.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.04 |
| Operating Margin | -2.38 |
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | -0.51 |
Income Statement
| Revenue | 747,000 |
| Revenue/Share | 0.28 |
| Gross Profit | 138,000 |
| EBITDA | -8.43M |
| Net Income | -3M |
| Diluted EPS | -6.45 |
Balance Sheet
| Total Cash | 3.34M |
| Total Cash/Share | 0.61 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.06 |
| Book Value Per Share | 1.24 |
Price History
| 52-Week Change | -96.68 |
| 52-Week High | 597.6 |
| 52-Week Low | 3.08 |
| Moving Average 50 Days | 8.11 |
| Moving Average 200 Days | 44.19 |
Statistics
| Average Volume | 1.81M |
| Shares Outstanding | 1.67M |
| % Held by Institutions | 3.62 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.03 |
| Last Split Factor | 1:15 |
| Last Split Date | July 07, 2025 |
